Cargando…

Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients

PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy...

Descripción completa

Detalles Bibliográficos
Autores principales: Opalinska, Marta, Stompor, Tomasz, Pach, Dorota, Mikolajczak, Renata, Fedak, Danuta, Krzanowski, Marcin, Rakowski, Tomasz, Sowa-Staszczak, Anna, Glowa, Boguslaw, Garnuszek, Piotr, Maurin, Michał, Karczmarczyk, Urszula, Sulowicz, Władysław, Hubalewska-Dydejczyk, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315638/
https://www.ncbi.nlm.nih.gov/pubmed/22237843
http://dx.doi.org/10.1007/s00259-011-2026-3
_version_ 1782228266034135040
author Opalinska, Marta
Stompor, Tomasz
Pach, Dorota
Mikolajczak, Renata
Fedak, Danuta
Krzanowski, Marcin
Rakowski, Tomasz
Sowa-Staszczak, Anna
Glowa, Boguslaw
Garnuszek, Piotr
Maurin, Michał
Karczmarczyk, Urszula
Sulowicz, Władysław
Hubalewska-Dydejczyk, Alicja
author_facet Opalinska, Marta
Stompor, Tomasz
Pach, Dorota
Mikolajczak, Renata
Fedak, Danuta
Krzanowski, Marcin
Rakowski, Tomasz
Sowa-Staszczak, Anna
Glowa, Boguslaw
Garnuszek, Piotr
Maurin, Michał
Karczmarczyk, Urszula
Sulowicz, Władysław
Hubalewska-Dydejczyk, Alicja
author_sort Opalinska, Marta
collection PubMed
description PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy with radiolabelled IL-2.The aim of this study was to identify the “inflamed” (vulnerable) plaques by scintigraphy using IL-2 labelled with (99m)Tc in the selected, high cardiovascular risk group of end-stage renal disease (ESRD) patients. METHODS: A total of 28 patients (18 men, 10 women, aged 55.2 ± 9.6 years, 17 on peritoneal dialysis, 11 on haemodialysis) underwent common carotid artery (CCA) scintigraphy with the use of (99m)Tc-hydrazinonicotinamide (HYNIC)-IL-2. In all cases, ultrasound examination of the CCA was performed and levels of selected proinflammatory factors, atherogenic markers and calcium-phosphate balance parameters were measured. Finally, the target to non-target (T/nT) ratio of IL-2 uptake in atherosclerotic plaques with intima-media thickness (IMT), classic cardiovascular risk factors and concentrations of the measured factors were compared. RESULTS: Increased (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques in 38/41 (91%) cases was detected. The median T/nT ratio of focal (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques was 2.35 (range 1.23–3.63). The mean IMT value on the side of plaques assessed by scintigraphy was 0.79 ± 0.18 mm (median 0.8, range 0.5–1.275). Correlations between T/nT ratio and homocysteine (R = 0.22, p = 0.037), apolipoprotein B (apoB) (R = 0.31, p = 0.008), apoB to apoA-I ratio (R = 0.29, p = 0.012) and triglyceride concentration (R = 0.26, p = 0.021) were detected. A lower T/nT ratio in patients with better parameters of nutritional status (haemoglobin, albumin, adiponectin) in comparison with patients with worse nutritional parameters (3.20 ± 0.5 vs 2.16 ± 0.68, p = 0.025) was revealed as well as a difference between values of T/nT ratio in groups of patients with values of apoB, soluble CD40 ligand and asymmetric dimethylarginine above and below median (3.18 ± 0.52 vs 2.16 ± 0.68, p = 0.031). No statistically significant association was found between T/nT ratio and mean value of either IMT or classic cardiovascular risk factors. CONCLUSION: Scintigraphy with the use of (99m)Tc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative results of carotid artery scintigraphy with (99m)Tc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers.
format Online
Article
Text
id pubmed-3315638
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-33156382012-04-05 Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients Opalinska, Marta Stompor, Tomasz Pach, Dorota Mikolajczak, Renata Fedak, Danuta Krzanowski, Marcin Rakowski, Tomasz Sowa-Staszczak, Anna Glowa, Boguslaw Garnuszek, Piotr Maurin, Michał Karczmarczyk, Urszula Sulowicz, Władysław Hubalewska-Dydejczyk, Alicja Eur J Nucl Med Mol Imaging Original Article PURPOSE: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy with radiolabelled IL-2.The aim of this study was to identify the “inflamed” (vulnerable) plaques by scintigraphy using IL-2 labelled with (99m)Tc in the selected, high cardiovascular risk group of end-stage renal disease (ESRD) patients. METHODS: A total of 28 patients (18 men, 10 women, aged 55.2 ± 9.6 years, 17 on peritoneal dialysis, 11 on haemodialysis) underwent common carotid artery (CCA) scintigraphy with the use of (99m)Tc-hydrazinonicotinamide (HYNIC)-IL-2. In all cases, ultrasound examination of the CCA was performed and levels of selected proinflammatory factors, atherogenic markers and calcium-phosphate balance parameters were measured. Finally, the target to non-target (T/nT) ratio of IL-2 uptake in atherosclerotic plaques with intima-media thickness (IMT), classic cardiovascular risk factors and concentrations of the measured factors were compared. RESULTS: Increased (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques in 38/41 (91%) cases was detected. The median T/nT ratio of focal (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques was 2.35 (range 1.23–3.63). The mean IMT value on the side of plaques assessed by scintigraphy was 0.79 ± 0.18 mm (median 0.8, range 0.5–1.275). Correlations between T/nT ratio and homocysteine (R = 0.22, p = 0.037), apolipoprotein B (apoB) (R = 0.31, p = 0.008), apoB to apoA-I ratio (R = 0.29, p = 0.012) and triglyceride concentration (R = 0.26, p = 0.021) were detected. A lower T/nT ratio in patients with better parameters of nutritional status (haemoglobin, albumin, adiponectin) in comparison with patients with worse nutritional parameters (3.20 ± 0.5 vs 2.16 ± 0.68, p = 0.025) was revealed as well as a difference between values of T/nT ratio in groups of patients with values of apoB, soluble CD40 ligand and asymmetric dimethylarginine above and below median (3.18 ± 0.52 vs 2.16 ± 0.68, p = 0.031). No statistically significant association was found between T/nT ratio and mean value of either IMT or classic cardiovascular risk factors. CONCLUSION: Scintigraphy with the use of (99m)Tc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative results of carotid artery scintigraphy with (99m)Tc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers. Springer-Verlag 2012-01-12 2012 /pmc/articles/PMC3315638/ /pubmed/22237843 http://dx.doi.org/10.1007/s00259-011-2026-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Opalinska, Marta
Stompor, Tomasz
Pach, Dorota
Mikolajczak, Renata
Fedak, Danuta
Krzanowski, Marcin
Rakowski, Tomasz
Sowa-Staszczak, Anna
Glowa, Boguslaw
Garnuszek, Piotr
Maurin, Michał
Karczmarczyk, Urszula
Sulowicz, Władysław
Hubalewska-Dydejczyk, Alicja
Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title_full Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title_fullStr Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title_full_unstemmed Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title_short Imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)Tc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients
title_sort imaging of inflamed carotid artery atherosclerotic plaques with the use of (99m)tc-hynic-il-2 scintigraphy in end-stage renal disease patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315638/
https://www.ncbi.nlm.nih.gov/pubmed/22237843
http://dx.doi.org/10.1007/s00259-011-2026-3
work_keys_str_mv AT opalinskamarta imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT stomportomasz imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT pachdorota imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT mikolajczakrenata imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT fedakdanuta imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT krzanowskimarcin imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT rakowskitomasz imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT sowastaszczakanna imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT glowaboguslaw imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT garnuszekpiotr imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT maurinmichał imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT karczmarczykurszula imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT sulowiczwładysław imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients
AT hubalewskadydejczykalicja imagingofinflamedcarotidarteryatheroscleroticplaqueswiththeuseof99mtchynicil2scintigraphyinendstagerenaldiseasepatients